Published in Lab Business Week, March 30th, 2008
"ESAs provide an unequivocal treatment benefit for cancer patients undergoing chemotherapy by reducing the need for blood transfusions," said Roger M. Perlmutter, M.D., Ph.D., executive vice president, of Research and Development at Amgen....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week